For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Blog
Free the Economy podcast: Obamacare problems with Jeremy Nighohossian
In this week’s episode we talk about the unintended consequences of the Sarbanes-Oxley Act of 2002, decarbonization of economic growth, and…
Blog
The problem with Obamacare is Obamacare
This year, the COVID-induced expansion of the Affordable Care Act (ACA) will expire. Extending the expanded subsidies has become a point of contention between…
News Release
Report: Pharmaceutical tariffs will upend prices, supply
A new CEI report takes a close look at the complex, worldwide pharmaceutical supply chain to anticipate how forthcoming Trump tariffs might increase prices…
Study
I, Pharmaceutical
The global pharmaceutical industry is complex. This is true not only in the number of countries involved but the range of products, the sets…
News Release
Trump’s views on Tylenol shouldn’t supersede doctor advice
President Trump railed against Tylenol (acetaminophen) in a press conference this week, imploring, in particular, pregnant women and babies to not take (or be…
Blog
Free the Economy podcast: Empowering patients with Vance Ginn
In this week’s episode we cover potential changes to quarterly reporting for public companies, state-level AI regulations, spiking gas prices…